Globus Medical, Inc.

Globus Medical, Inc.

GMEDยทNYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio19.59
Earnings Date07/30/2026
Globus Medical, Inc.

Globus Medical, Inc. Fair Value Envelope

GMED ยท NYSE

Our analysis suggests that GMED has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $77.95, this represents a potential HIDDEN relative to our calculated worth for Globus Medical, Inc..

Intrinsic Value
Current Price: $77.95

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$289.7B
+ Cash & Equivalents$526.2M
Firm Value$290.2B
- Debt$118.7M
Equity Value$290.1B
/ Shares Outstanding133,832,422B
DCF Value$2.2K
UNDERVALUED BY 2681%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$1.1B
$1.6B
$2.3B
$3.4B
$4.9B
$7.1B
$10.3B
$15.0B
$21.7B
$31.6B
Maintenance CapEx
-$47.9M
-$69.5M
-$101.0M
-$146.8M
-$213.3M
-$309.9M
-$450.3M
-$654.3M
-$950.7M
-$1.4B
Owner Earnings
$1.0B
$1.5B
$2.2B
$3.2B
$4.7B
$6.8B
$9.9B
$14.3B
$20.8B
$30.2B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$969.4M
$1.3B
$1.8B
$2.4B
$3.2B
$4.3B
$5.7B
$7.7B
$10.4B
$14.0B
Terminal Value represents 82.1% of Enterprise Value